NVX-CoV2373(Novavax COVID-19 Vaccine)
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
Shinde V, et al.〔N Engl J Med. 2021 May 20;384(20):1899-1909〕(査読済み)
Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
Heath P, et al.〔N Engl J Med. 2021 Jun 30;NEJMoa2107659〕(査読済み)
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
Khoury DS, et al.〔Nat Med. 2021 May 17〕(査読済み)
Safety, Immunogenicity, and Efficacy of a COVID-19 Vaccine (NVX-CoV2373) Co-administered With Seasonal Influenza Vaccines
Toback S, et al.〔medRxiv. 2021 Jun 13〕(査読前)
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico
Dunkle LM, et al.〔N Engl J Med. 2021 Dec 15;NEJMoa2116185〕(査読済み)